Vanguard Group
WINT

Vanguard Group’s Windtree Therapeutics Inc WINT Stock Holding History

Vanguard Group’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-151,623
Closed -$173K – 4124
2017
Q1 		$173K Buy
151,623
+8,500
+6% +$11K ﹤0.01% 3923
2016
Q4 		$177K Sell
143,123
-32,209
-18% -$59.5K ﹤0.01% 3911
2016
Q3 		$450K Sell
175,332
-23,471
-12% -$51.1K ﹤0.01% 3780
2016
Q2 		$384K Buy
198,803
+2,380
+1% +$5.75K ﹤0.01% 3835
2016
Q1 		$324K Buy
196,423
+14,068
+8% +$30.2K ﹤0.01% 3874
2015
Q4 		$546K Buy
182,355
+1,128
+0.6% +$4.63K ﹤0.01% 3810
2015
Q3 		$761K Buy
181,227
+980
+0.5% +$6.49K ﹤0.01% 3721
2015
Q2 		$1.72M Buy
180,247
+8,766
+5% +$123K ﹤0.01% 3475
2015
Q1 		$2.86M Buy
171,481
+6,888
+4% +$136K ﹤0.01% 3261
2014
Q4 		$2.67M Buy
164,593
+3,686
+2% +$81K ﹤0.01% 3176
2014
Q3 		$4.14M Buy
160,907
+17,816
+12% +$430K ﹤0.01% 2931
2014
Q2 		$3.57M Buy
143,091
+756
+0.5% +$19.3K ﹤0.01% 3002
2014
Q1 		$4.28M Buy
142,335
+22,479
+19% +$756K ﹤0.01% 2910
2013
Q4 		$3.78M Buy
119,856
+57,071
+91% +$1.78M ﹤0.01% 2937
2013
Q3 		$1.72M Buy
62,785
+1,824
+3% +$44.2K ﹤0.01% 3190
2013
Q2 		$1.3M Buy
+60,961
New +$1.5M ﹤0.01% 3228

Other funds holding WINT

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Vanguard Group's WINT Position: Q2 2017 in Review

Vanguard Group sold out of Windtree Therapeutics Inc (WINT) in Q2 2017, closing a stake of 151,623 shares — an estimated $173K sold.

Vanguard Group first reported a position in WINT in Q2 2013 and held it in 16 quarters. The position peaked at $4.28M in Q1 2014. 3 funds tracked by Wall St. Rank hold WINT as of Q2 2017.

  • Vanguard Group reported no remaining Windtree Therapeutics Inc position as of Q2 2017 after selling out during the quarter.
  • Vanguard Group sold 151,623 Windtree Therapeutics Inc shares in Q2 2017, an estimated $173K.
  • Vanguard Group first reported a position in Windtree Therapeutics Inc in Q2 2013 and held it in 16 quarters.
  • Vanguard Group's Windtree Therapeutics Inc position peaked at $4.28M in Q1 2014.
  • 3 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q2 2017.

Based on Vanguard Group's 13F filing for Q2 2017, filed 11 Aug 2017.